Americans spend an estimated $60 billion a year on biologically derived medications, or biologics, to treat diseases like cancer and rheumatoid arthritis. California is home to a lot of the firms that make them and a lot of the people who use them, and the state's congressional delegation is influencing how they'll be treated in health care legislation.
upper waypoint
lower waypoint
next waypoint
To learn more about how we use your information, please read our privacy policy.